Clinical benefits of methylprednisolone in off-pump coronary artery bypass surgery

Takanori Suezawa, Atsushi Aoki, Mitsuhisa Kotani, Mamoru Tago, Osamu Kobayashi, Akihito Hirasaki, Minako Sano, Nana Kameda, Hiroki Mitsunaka

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: It has not been established whether off-pump coronary artery bypass grafting (OPCABG) is less invasive than conventional CABG. In our experience, OPCABG has several advantages such as shorter operative duration, decreased requirement of blood transfusion and myocardial protection compared with conventional CABG. However, frequency of postoperative paroxysmal atrial fibrillation (PAF) is similar between these techniques and early postoperative C-reactive protein (CRP) levels have been shown to be significantly higher in OPCABG. We hypothesized that preoperative steroid administration, routinely used only in conventional CABG, may alleviate high postoperative PAF and CRP levels. Therefore, a prospective, double-blind, clinical trial was conducted in OPCABG patients to investigate the clinical effects of preoperative steroid administration. Methods: Thirty OPCABG patients were randomly divided into 2 groups: control (Group C: n = 15) and methylprednisolone (Group M: n = 15) groups. Group M patients were intravenously administered 1000 mg methylprednisolone during anesthesia induction. Results: Hospital death and infectious complication such as mediastinitis were not observed in either group. Postoperative PAF occurred in 47 % (7/15) of patients in group C but in only 1 patient in group M (7 %, P = 0.013). Early postoperative CRP levels were significantly lower in group M than in group C (peak values on postoperative day 2: group M 15 ± 6 mg/dL vs. group C 23 ± 4 mg/dL; P = 0.0002). Conclusions: Preoperative steroid administration in OPCABG patients significantly suppresses CRP elevation and prevents postoperative PAF without increasing in-hospital mortality or infectious complications.

Original languageEnglish
Pages (from-to)455-459
Number of pages5
JournalGeneral Thoracic and Cardiovascular Surgery
Volume61
Issue number8
DOIs
Publication statusPublished - Aug 1 2013
Externally publishedYes

Fingerprint

Off-Pump Coronary Artery Bypass
Methylprednisolone
Coronary Artery Bypass
C-Reactive Protein
Atrial Fibrillation
Steroids
Mediastinitis
Hospital Mortality
Blood Transfusion
Anesthesia
Clinical Trials
Control Groups

Keywords

  • Atrial fibrillation
  • Inflammation
  • Methylprednisolone
  • Off-pump coronary artery bypass

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Clinical benefits of methylprednisolone in off-pump coronary artery bypass surgery. / Suezawa, Takanori; Aoki, Atsushi; Kotani, Mitsuhisa; Tago, Mamoru; Kobayashi, Osamu; Hirasaki, Akihito; Sano, Minako; Kameda, Nana; Mitsunaka, Hiroki.

In: General Thoracic and Cardiovascular Surgery, Vol. 61, No. 8, 01.08.2013, p. 455-459.

Research output: Contribution to journalArticle

Suezawa, T, Aoki, A, Kotani, M, Tago, M, Kobayashi, O, Hirasaki, A, Sano, M, Kameda, N & Mitsunaka, H 2013, 'Clinical benefits of methylprednisolone in off-pump coronary artery bypass surgery', General Thoracic and Cardiovascular Surgery, vol. 61, no. 8, pp. 455-459. https://doi.org/10.1007/s11748-013-0206-8
Suezawa, Takanori ; Aoki, Atsushi ; Kotani, Mitsuhisa ; Tago, Mamoru ; Kobayashi, Osamu ; Hirasaki, Akihito ; Sano, Minako ; Kameda, Nana ; Mitsunaka, Hiroki. / Clinical benefits of methylprednisolone in off-pump coronary artery bypass surgery. In: General Thoracic and Cardiovascular Surgery. 2013 ; Vol. 61, No. 8. pp. 455-459.
@article{005f56a7f4b64ac29c6a0b223213a900,
title = "Clinical benefits of methylprednisolone in off-pump coronary artery bypass surgery",
abstract = "Background: It has not been established whether off-pump coronary artery bypass grafting (OPCABG) is less invasive than conventional CABG. In our experience, OPCABG has several advantages such as shorter operative duration, decreased requirement of blood transfusion and myocardial protection compared with conventional CABG. However, frequency of postoperative paroxysmal atrial fibrillation (PAF) is similar between these techniques and early postoperative C-reactive protein (CRP) levels have been shown to be significantly higher in OPCABG. We hypothesized that preoperative steroid administration, routinely used only in conventional CABG, may alleviate high postoperative PAF and CRP levels. Therefore, a prospective, double-blind, clinical trial was conducted in OPCABG patients to investigate the clinical effects of preoperative steroid administration. Methods: Thirty OPCABG patients were randomly divided into 2 groups: control (Group C: n = 15) and methylprednisolone (Group M: n = 15) groups. Group M patients were intravenously administered 1000 mg methylprednisolone during anesthesia induction. Results: Hospital death and infectious complication such as mediastinitis were not observed in either group. Postoperative PAF occurred in 47 {\%} (7/15) of patients in group C but in only 1 patient in group M (7 {\%}, P = 0.013). Early postoperative CRP levels were significantly lower in group M than in group C (peak values on postoperative day 2: group M 15 ± 6 mg/dL vs. group C 23 ± 4 mg/dL; P = 0.0002). Conclusions: Preoperative steroid administration in OPCABG patients significantly suppresses CRP elevation and prevents postoperative PAF without increasing in-hospital mortality or infectious complications.",
keywords = "Atrial fibrillation, Inflammation, Methylprednisolone, Off-pump coronary artery bypass",
author = "Takanori Suezawa and Atsushi Aoki and Mitsuhisa Kotani and Mamoru Tago and Osamu Kobayashi and Akihito Hirasaki and Minako Sano and Nana Kameda and Hiroki Mitsunaka",
year = "2013",
month = "8",
day = "1",
doi = "10.1007/s11748-013-0206-8",
language = "English",
volume = "61",
pages = "455--459",
journal = "General Thoracic and Cardiovascular Surgery",
issn = "1863-6705",
publisher = "Springer Japan",
number = "8",

}

TY - JOUR

T1 - Clinical benefits of methylprednisolone in off-pump coronary artery bypass surgery

AU - Suezawa, Takanori

AU - Aoki, Atsushi

AU - Kotani, Mitsuhisa

AU - Tago, Mamoru

AU - Kobayashi, Osamu

AU - Hirasaki, Akihito

AU - Sano, Minako

AU - Kameda, Nana

AU - Mitsunaka, Hiroki

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Background: It has not been established whether off-pump coronary artery bypass grafting (OPCABG) is less invasive than conventional CABG. In our experience, OPCABG has several advantages such as shorter operative duration, decreased requirement of blood transfusion and myocardial protection compared with conventional CABG. However, frequency of postoperative paroxysmal atrial fibrillation (PAF) is similar between these techniques and early postoperative C-reactive protein (CRP) levels have been shown to be significantly higher in OPCABG. We hypothesized that preoperative steroid administration, routinely used only in conventional CABG, may alleviate high postoperative PAF and CRP levels. Therefore, a prospective, double-blind, clinical trial was conducted in OPCABG patients to investigate the clinical effects of preoperative steroid administration. Methods: Thirty OPCABG patients were randomly divided into 2 groups: control (Group C: n = 15) and methylprednisolone (Group M: n = 15) groups. Group M patients were intravenously administered 1000 mg methylprednisolone during anesthesia induction. Results: Hospital death and infectious complication such as mediastinitis were not observed in either group. Postoperative PAF occurred in 47 % (7/15) of patients in group C but in only 1 patient in group M (7 %, P = 0.013). Early postoperative CRP levels were significantly lower in group M than in group C (peak values on postoperative day 2: group M 15 ± 6 mg/dL vs. group C 23 ± 4 mg/dL; P = 0.0002). Conclusions: Preoperative steroid administration in OPCABG patients significantly suppresses CRP elevation and prevents postoperative PAF without increasing in-hospital mortality or infectious complications.

AB - Background: It has not been established whether off-pump coronary artery bypass grafting (OPCABG) is less invasive than conventional CABG. In our experience, OPCABG has several advantages such as shorter operative duration, decreased requirement of blood transfusion and myocardial protection compared with conventional CABG. However, frequency of postoperative paroxysmal atrial fibrillation (PAF) is similar between these techniques and early postoperative C-reactive protein (CRP) levels have been shown to be significantly higher in OPCABG. We hypothesized that preoperative steroid administration, routinely used only in conventional CABG, may alleviate high postoperative PAF and CRP levels. Therefore, a prospective, double-blind, clinical trial was conducted in OPCABG patients to investigate the clinical effects of preoperative steroid administration. Methods: Thirty OPCABG patients were randomly divided into 2 groups: control (Group C: n = 15) and methylprednisolone (Group M: n = 15) groups. Group M patients were intravenously administered 1000 mg methylprednisolone during anesthesia induction. Results: Hospital death and infectious complication such as mediastinitis were not observed in either group. Postoperative PAF occurred in 47 % (7/15) of patients in group C but in only 1 patient in group M (7 %, P = 0.013). Early postoperative CRP levels were significantly lower in group M than in group C (peak values on postoperative day 2: group M 15 ± 6 mg/dL vs. group C 23 ± 4 mg/dL; P = 0.0002). Conclusions: Preoperative steroid administration in OPCABG patients significantly suppresses CRP elevation and prevents postoperative PAF without increasing in-hospital mortality or infectious complications.

KW - Atrial fibrillation

KW - Inflammation

KW - Methylprednisolone

KW - Off-pump coronary artery bypass

UR - http://www.scopus.com/inward/record.url?scp=84881481971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881481971&partnerID=8YFLogxK

U2 - 10.1007/s11748-013-0206-8

DO - 10.1007/s11748-013-0206-8

M3 - Article

C2 - 23381198

AN - SCOPUS:84881481971

VL - 61

SP - 455

EP - 459

JO - General Thoracic and Cardiovascular Surgery

JF - General Thoracic and Cardiovascular Surgery

SN - 1863-6705

IS - 8

ER -